Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Harrow Inc (NQ: HROW ) 39.48 +0.56 (+1.44%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Harrow Inc < Previous 1 2 3 4 5 6 7 Next > Recap: Harrow Health Q2 Earnings August 09, 2022 Harrow Health (NASDAQ:HROW) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Via Benzinga Harrow Health Announces Second Quarter 2022 Financial Results August 09, 2022 From Harrow Health, Inc. Via Business Wire Harrow Health to Announce Second Quarter 2022 Financial Results on August 9, 2022 July 27, 2022 From Harrow Health, Inc. Via Business Wire Earnings Scheduled For March 10, 2022 March 10, 2022 Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... Via Benzinga Earnings Scheduled For August 10, 2021 August 10, 2021 Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:... Via Benzinga Harrow Health Announces Launch of IOPIDINE® 1% and MAXITROL® in the United States June 24, 2022 From Harrow Health, Inc. Via Business Wire 7 Mighty Micro-Cap Stocks That Could Be Future Moonshots May 30, 2022 These seven micro-cap stocks, either due to catalysts or a low valuation, could make a move to substantially higher prices. Via InvestorPlace Harrow Health Announces First Quarter 2022 Financial Results May 05, 2022 From Harrow Health, Inc. Via Business Wire Melt Pharmaceuticals Announces MELT-210 Top-Line Results of Phase 1 Pharmacokinetics (PK) Study for Procedural Sedation May 04, 2022 From Melt Pharmaceuticals, Inc. Via Business Wire Harrow Health to Participate in B. Riley Securities’ Annual Neuro & Ophthalmology Investor Conference April 22, 2022 From Harrow Health, Inc. Via Business Wire Harrow Health to Announce First Quarter 2022 Financial Results on May 5, 2022 April 20, 2022 From Harrow Health, Inc. Via Business Wire Harrow Health Announces Appointments to Its Board of Directors March 31, 2022 From Harrow Health, Inc. Via Business Wire Harrow Health to Announce Fourth Quarter and Year-End 2021 Financial Results on March 10, 2022 February 24, 2022 From Harrow Health, Inc. Via Business Wire Harrow Health Announces FDA Acceptance of New Drug Application for AMP-100 February 22, 2022 From Harrow Health, Inc. Via Business Wire Harrow Health to Present at Aegis Virtual Conference February 15, 2022 From Harrow Health, Inc. Via Business Wire Two Insider Moonshots Rising on Sudden Buying February 10, 2022 Biotech insiders are among the most important investors to pay close attention to. Here are two that show good signs for the future. Via InvestorPlace Harrow Health Publishes Corporate Transparency Report February 08, 2022 From Harrow Health, Inc. Via Business Wire Harrow Health to Participate in H.C. Wainwright BioConnect Conference January 10, 2022 From Harrow Health, Inc. Via Business Wire Melt Pharmaceuticals Submits INDs for MELT‑210 and MELT-400 to FDA January 04, 2022 From Melt Pharmaceuticals, Inc. Via Business Wire Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops December 20, 2021 From Harrow Health, Inc. Via Business Wire Harrow Health Added to the Nasdaq Biotechnology Index December 13, 2021 From Harrow Health, Inc. Via Business Wire The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom December 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus EyePoint Announces Commercialization Agreement For Dexycu To Treat Post-... Via Benzinga Topics Intellectual Property Lawsuit Exposures Financial Intellectual Property Legal Harrow Health Announces Third Quarter 2021 Financial Results November 09, 2021 From Harrow Health, Inc. Via Business Wire Harrow Health to Announce Third Quarter 2021 Financial Results on November 9, 2021 October 25, 2021 From Harrow Health, Inc. Via Business Wire Harrow Health Provides $13.5 Million Senior Secured Loan to Melt Pharmaceuticals September 02, 2021 From Harrow Health, Inc. Via Business Wire Harrow Health Acquires Japan-Approved Ophthalmic Injection For Undisclosed Sum August 18, 2021 For an undisclosed amount, Harrow Health Inc (NASDAQ: HROW) has agreed to acquire MAQ-100 U.S. and Canadian commercial rights from Wakamoto... Via Benzinga Harrow Health Acquires Ophthalmic Surgical Drug Candidate From Wakamoto Pharmaceutical Co., Ltd. August 18, 2021 From Harrow Health, Inc. Via Business Wire Harrow Health to Participate in Two Upcoming Virtual Investor Conferences August 12, 2021 From Harrow Health, Inc. Via Business Wire Harrow Health: Q2 Earnings Insights August 10, 2021 Shares of Harrow Health (NASDAQ:HROW) were flat after the company reported Q2 results. Quarterly Results Earnings per share decreased 1000.00% year over year to ($0.11),... Via Benzinga Harrow Health Announces Second Quarter 2021 Financial Results August 10, 2021 From Harrow Health, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.